Refad Real Estate Investment and Development, a subsidiary of Al Qahtani Holding Group, has officially launched Miraf District in Al Khobar, marking a milestone in the Eastern Province’s urban ...

(MENAFN- EIN Presswire) EINPresswire / -- Modern cities are no longer measured by their towers but by their ability to create daily experiences that meet people's needs. From this vision, Miraf ...

Refad Real Estate Investment and Development, a subsidiary of Al-Qahtani Holding Group, has announced the official launch of “Miraf District” in Al-Khobar. The project introduces a first-of-its-kind ...

The list of enterprises targeted by recent Oracle EBS attacks may also include Schneider Electric, Pan American Steel, and Cox Enterprises. Earlier this month, the infamous ransomware-as-a-service ...

Gensler announced its appointment as the lead consultant for Miraf District, a new mixed-use destination developed by Refad Real Estate Investment & Development (Refad). Located along King Faisal Road ...

Al Khobar, Saudi Arabia: Gensler, the most impactful global architecture, design, and planning firm, today announces its appointment as the lead consultant for Miraf District, a new mixed-use ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

Information disclosure flaw, CVE-2025-61884, emerges weeks after zero-day attacks, raising questions about broader security issues in Oracle’s flagship ERP platform. Oracle has issued its second ...

Oracle has issued an emergency security update over the weekend to patch another E-Business Suite (EBS) vulnerability that can be exploited remotely by unauthenticated attackers. Tracked as ...

Oracle has advised customers that hackers may be exploiting vulnerabilities in unpatched instances of its E-Business Suite (EBS). This follows a warning by the Google Threat Intelligence Group (GTIG) ...

The market for Emergent BioSolutions Inc.'s (NYSE:EBS) stock was strong after it released a healthy earnings report last week. However, we think that shareholders should be cautious as we found some ...

Emergent BioSolutions delivered a strong Q2 2025, beating its own guidance and showing major improvements in margins. EBS has a sound turnaround strategy that is showing signs of success. The company ...